Although recent years have seen a rapid developing momentum in China,however,the capital input of Chinas enterprises is much less than that of enterprises in developed countries especially the United States.Besides,there is a significant shortfall in short-term funds of Chinese biopharmaceutical enterprises.To make clear the source of funds for the industrialization of Biopharmaceutical Enterprises,this paper summarizes the source of financing the enterprises can choose with various degrees of innovation.